{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:52:51Z","timestamp":1791193971430,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1002\/jps.20327","type":"journal-article","created":{"date-parts":[[2005,3,29]],"date-time":"2005-03-29T23:46:30Z","timestamp":1112139990000},"page":"1060-1066","source":"Crossref","is-referenced-by-count":67,"title":["Oxycodone Pharmacokinetics and Pharmacodynamics in the Rat in the Presence of the P-Glycoprotein Inhibitor PSC833"],"prefix":"10.1016","volume":"94","author":[{"given":"Emma","family":"Bostr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika S.H.","family":"Simonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Hammarlund-Udenaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20327_bb0010","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0024-3205(99)00148-4","article-title":"Opioid binding profiles of new hydrazone, oxime, carbazone and semicarbazone derivatives of 14-alkoxymorphinans","volume":"64","author":"Monory","year":"1999","journal-title":"Life Sci"},{"key":"10.1002\/jps.20327_bb0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0304-3959(99)00230-4","article-title":"Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats","volume":"84","author":"Ross","year":"2000","journal-title":"Pain"},{"key":"10.1002\/jps.20327_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-0773.1992.tb00441.x","article-title":"Antinociceptive effects and central nervous system depression caused by oxycodone and morphine in rats","volume":"70","author":"Poyhia","year":"1992","journal-title":"Pharmacol Toxicol"},{"key":"10.1002\/jps.20327_bb0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00520-002-0385-9","article-title":"Normal-release and controlled-release oxycodone: Pharmacokinetics, pharmacodynamics, and controversy","volume":"11","author":"Davis","year":"2003","journal-title":"Support Care Cancer"},{"key":"10.1002\/jps.20327_bb0030","doi-asserted-by":"crossref","first-page":"7735","DOI":"10.1073\/pnas.84.21.7735","article-title":"Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues","volume":"84","author":"Thiebaut","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jps.20327_bb0035","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1073\/pnas.86.2.695","article-title":"Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites","volume":"86","author":"Cordon-Cardo","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jps.20327_bb0040","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/00000542-200005000-00030","article-title":"Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein","volume":"92","author":"Thompson","year":"2000","journal-title":"Anesthesiology"},{"issue":"1\u20132","key":"10.1002\/jps.20327_bb0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00213-003-1718-1","article-title":"Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice","volume":"173","author":"Wang","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1002\/jps.20327_bb0050","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00008571-200311000-00001","article-title":"Effects of ABCB1 (multidrug resistance transporter) gene mutations on disposition and central nervous effects of loperamide in healthy volunteers","volume":"13","author":"Skarke","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1002\/jps.20327_bb0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0024-3205(97)00370-6","article-title":"Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine","volume":"61","author":"Desrayaud","year":"1997","journal-title":"Life Sci"},{"key":"10.1002\/jps.20327_bb0060","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/rcm.1658","article-title":"The use of liquid chromatography\/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue","volume":"18","author":"Bostrom","year":"2004","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1002\/jps.20327_bb0065","first-page":"827","article-title":"Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat","volume":"27","author":"Letrent","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.20327_bb0070","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: Implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.20327_bb0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1067\/mcp.2000.109156","article-title":"Increased drug delivery to the brain by P-glycoprotein inhibition","volume":"68","author":"Sadeque","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/jps.20327_bb0080","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1172\/JCI0215451","article-title":"Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo","volume":"110","author":"Fellner","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1002\/jps.20327_bb0085","first-page":"1058","article-title":"The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells","volume":"28","author":"Washington","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.20327_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)00423-8","article-title":"P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: Evidence from microdialysis experiments in rats","volume":"327","author":"Potschka","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1002\/jps.20327_bb0095","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/abbi.1997.0537","article-title":"Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene","volume":"350","author":"Schuetz","year":"1998","journal-title":"Arch Biochem Biophys"},{"key":"10.1002\/jps.20327_bb0100","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1124\/mol.56.6.1219","article-title":"Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter","volume":"56","author":"Chen","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1002\/jps.20327_bb0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-8993(03)02401-6","article-title":"Characterisation of the brain multidrug resistance protein (BMDP\/ABCG2\/BCRP) expressed at the blood-brain barrier","volume":"971","author":"Eisenbl\u00e4tter","year":"2003","journal-title":"Brain Res"},{"key":"10.1002\/jps.20327_bb0110","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1172\/JCI119784","article-title":"Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833","volume":"100","author":"Mayer","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1002\/jps.20327_bb0115","first-page":"866","article-title":"OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine","volume":"27","author":"Cvetkovic","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.20327_bb0120","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0006-291X(02)00376-5","article-title":"A new multidrug resistance protein at the blood-brain barrier","volume":"293","author":"Eisenbl\u00e4tter","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/jps.20327_bb0125","first-page":"717","article-title":"Expression and localization of multidrug resistant protein mrp2 in rat small intestine","volume":"293","author":"Mottino","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.20327_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-2559.2002.01403.x","article-title":"Expression of multidrug resistance-associated protein 2 (MRP2) in normal human tissues and carcinomas using tissue microarrays","volume":"41","author":"Sandusky","year":"2002","journal-title":"Histopathology"},{"key":"10.1002\/jps.20327_bb0135","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1177\/002215549904701005","article-title":"Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain","volume":"47","author":"Gao","year":"1999","journal-title":"J Histochem Cytochem"},{"key":"10.1002\/jps.20327_bb0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(01)01640-8","article-title":"Uptake and efflux of the peptidic delta-opioid receptor agonist [D-penicillamine2,5]-enkephalin at the murine blod-brain barrier by in situ perfusion","volume":"301","author":"Dagenais","year":"2001","journal-title":"Neurosci Lett"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916317646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916317646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T15:24:12Z","timestamp":1586186652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916317646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0022354916317646"],"URL":"https:\/\/doi.org\/10.1002\/jps.20327","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}